Skip to content
← All treatment topics

TREATMENT READING

Childhood Salivary Gland Tumors

Source sections for this topic, with the original link and date. Patient and professional reading are labelled separately.

Not medical advice · Not a complete treatment or trial directory

Made by Triangle.

Selected text from the National Cancer Institute, with the original link and date. Made by Triangle. This page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.

Health professional · Salivary Gland Tumors

Treatment of Childhood Salivary Gland Tumors

Source: Childhood Salivary Gland Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: August 23, 2024. Captured 2026-09-09.

The European Cooperative Study Group for Pediatric Rare Tumors within the PARTNER project (Paediatric Rare Tumours Network - European Registry) has published consensus guidelines for the diagnosis and treatment of childhood salivary gland tumors.[31]

Sources: 31

Treatment options for childhood salivary gland tumors include the following:

Surgery.

Sources: Surgery

Radiation therapy.

Sources: Radiation therapy

Targeted therapy.

Sources: Targeted therapy

This page is made by Triangle. The reading above is selected source text, not a treatment recommendation, and it is not medical advice.

Health professional · Salivary Gland Tumors / Treatment of Childhood Salivary Gland Tumors

Surgery

Source: Childhood Salivary Gland Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: August 23, 2024. Captured 2026-09-09.

Radical surgical removal is the treatment of choice for salivary gland tumors whenever possible, with additional use of radiation therapy for high-grade tumors or tumors that have invasive characteristics such as LNM, positive surgical margins, extracapsular extension, or perineural extension.[24,32,33]; [9][Level of evidence C1] Parotid gland tumors are removed with the aid of neurological monitoring to prevent damage to the facial nerve.

Sources: 24 · 32 · 33 · 9 · Level of evidence C1

Health professional · Salivary Gland Tumors / Treatment of Childhood Salivary Gland Tumors

Radiation therapy

Source: Childhood Salivary Gland Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: August 23, 2024. Captured 2026-09-09.

In an international systematic review of 2,215 pediatric patients with malignant salivary tumors, 28.9% received surgery and radiation therapy, 1.8% received surgery, radiation therapy, and chemotherapy, and 0.2% received radiation therapy alone.[12] One retrospective study compared proton therapy with conventional radiation therapy and found that proton therapy had a favorable acute toxicity and dosimetric profile.[34] Another retrospective study used brachytherapy with iodine I 125 seeds to treat 24 children with mucoepidermoid carcinoma who had high-risk factors. Seeds were implanted within 4 weeks of surgical resection. With a median follow-up of 7.2 years, the disease-free survival and OS rates were 100%. No severe radiation-associated complications were reported.[35][Level of evidence C2]

Sources: 12 · 34 · 35 · Level of evidence C2

Health professional · Salivary Gland Tumors / Treatment of Childhood Salivary Gland Tumors

Targeted therapy

Source: Childhood Salivary Gland Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: August 23, 2024. Captured 2026-09-09.

Objective responses have been observed in all reported patients with recurrent NTRK fusion–positive MASC who were treated with entrectinib or larotrectinib.[36,37] Ten of 11 adolescent or adult patients with TRK fusion–positive salivary gland tumors who were treated with larotrectinib experienced partial or complete responses.[37]

Sources: 36 · 37 · 37

For more information, see Salivary Gland Cancer Treatment.

Sources: Salivary Gland Cancer Treatment

Health professional · Salivary Gland Tumors

Treatment Options Under Clinical Evaluation for Childhood Salivary Gland Tumors

Source: Childhood Salivary Gland Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: August 23, 2024. Captured 2026-09-09.

Information about National Cancer Institute (NCI)–supported clinical trials can be found on the NCI website. For information about clinical trials sponsored by other organizations, see the ClinicalTrials.gov website.

Sources: NCI website · ClinicalTrials.gov website

Health professional

Special Considerations for the Treatment of Children With Cancer

Source: Childhood Salivary Gland Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: August 23, 2024. Captured 2026-09-09.

Cancer in children and adolescents is rare, although the overall incidence has slowly increased since 1975.[1] Children and adolescents with cancer should be referred to medical centers that have a multidisciplinary team of cancer specialists with experience treating the cancers that occur during childhood and adolescence. This multidisciplinary team approach incorporates the skills of the following pediatric specialists and others to ensure that children receive treatment, supportive care, and rehabilitation to achieve optimal survival and quality of life:

Sources: 1

Primary care physicians.

Pediatric surgeons.

Pathologists.

Pediatric radiation oncologists.

Pediatric medical oncologists and hematologists.

Ophthalmologists.

Rehabilitation specialists.

Pediatric oncology nurses.

Social workers.

Child-life professionals.

Psychologists.

Nutritionists.

For specific information about supportive care for children and adolescents with cancer, see the summaries on Supportive and Palliative Care.

Sources: Supportive and Palliative Care

The American Academy of Pediatrics has outlined guidelines for pediatric cancer centers and their role in the treatment of children and adolescents with cancer.[2] At these centers, clinical trials are available for most types of cancer that occur in children and adolescents, and the opportunity to participate is offered to most patients and their families. Clinical trials for children and adolescents diagnosed with cancer are generally designed to compare potentially better therapy with current standard therapy. Other types of clinical trials test novel therapies when there is no standard therapy for a cancer diagnosis. Most of the progress in identifying curative therapies for childhood cancers has been achieved through clinical trials. Information about ongoing clinical trials is available from the NCI website.

Sources: 2 · NCI website

Dramatic improvements in survival have been achieved for children and adolescents with cancer. Between 1975 and 2020, childhood cancer mortality decreased by more than 50%.[3-5] Childhood and adolescent cancer survivors require close monitoring because side effects of cancer therapy may persist or develop months or years after treatment. For information about the incidence, type, and monitoring of late effects in childhood and adolescent cancer survivors, see Late Effects of Treatment for Childhood Cancer.

Sources: 3 · 5 · Late Effects of Treatment for Childhood Cancer

Childhood cancer is a rare disease, with about 15,000 cases diagnosed annually in the United States in individuals younger than 20 years.[6] The U.S. Rare Diseases Act of 2002 defines a rare disease as one that affects populations smaller than 200,000 people in the United States. Therefore, all pediatric cancers are considered rare.

Sources: 6 · Rare Diseases Act of 2002

The designation of a rare tumor is not uniform among pediatric and adult groups. In adults, rare cancers are defined as those with an annual incidence of fewer than six cases per 100,000 people. They account for up to 24% of all cancers diagnosed in the European Union and about 20% of all cancers diagnosed in the United States.[7,8] In children and adolescents, the designation of a rare tumor is not uniform among international groups, as follows:

Sources: 7 · 8

A consensus effort between the European Union Joint Action on Rare Cancers and the European Cooperative Study Group for Rare Pediatric Cancers estimated that 11% of all cancers in patients younger than 20 years could be categorized as very rare. This consensus group defined very rare cancers as those with annual incidences of fewer than two cases per 1 million people. However, three additional histologies (thyroid carcinoma, melanoma, and testicular cancer) with incidences of more than two cases per 1 million people were also included in the very rare group due to a lack of knowledge and expertise in the management of these tumors.[9]

Sources: 9

The Children's Oncology Group defines rare pediatric cancers as those listed in the International Classification of Childhood Cancer subgroup XI, which includes thyroid cancers, melanomas and nonmelanoma skin cancers, and multiple types of carcinomas (e.g., adrenocortical carcinomas, nasopharyngeal carcinomas, and most adult-type carcinomas such as breast cancers and colorectal cancers).[10] These diagnoses account for about 5% of the cancers diagnosed in children aged 0 to 14 years and about 27% of the cancers diagnosed in adolescents aged 15 to 19 years.[4] Most cancers in subgroup XI are either melanomas or thyroid cancers, with other cancer types accounting for only 2% of the cancers diagnosed in children aged 0 to 14 years and 9.3% of the cancers diagnosed in adolescents aged 15 to 19 years.

Sources: 10 · 4

These rare cancers are extremely challenging to study because of the relatively few patients with any individual diagnosis, the predominance of rare cancers in the adolescent population, and the small number of clinical trials for adolescents with rare cancers.

Information about these tumors may also be found in sources relevant to adults with cancer, such as Salivary Gland Cancer Treatment.

Sources: Salivary Gland Cancer Treatment

For patients

Treatment of childhood salivary gland tumors

Source: Childhood Salivary Gland Tumors (PDQ®)–Patient Version, National Cancer Institute.

Source updated: October 10, 2024. Captured 2026-09-09.

There are different types of treatment for children and adolescents with salivary gland tumors. You and your child's care team will work together to decide treatment. Many factors will be considered, such as your child's overall health and whether the tumor is newly diagnosed or has come back.

Your child's treatment plan will include information about the tumor, the goals of treatment, treatment options, and the possible side effects. It will be helpful to talk with your child’s care team before treatment begins about what to expect. For help every step of the way, see our booklet, Children with Cancer: A Guide for Parents.

Sources: Children with Cancer: A Guide for Parents

Treatment of salivary gland tumors may include:

Surgery to remove salivary gland tumors or salivary gland cancer is the most common treatment. If the parotid gland is removed during surgery, special care must be taken to avoid damage to the facial nerve. Learn more about Surgery to Treat Cancer.

Sources: facial nerve · Surgery to Treat Cancer

Radiation therapy may be given after surgery for salivary gland cancer. Radiation therapy uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. Salivary gland cancer may be treated with external beam radiation therapy or internal radiation therapy if the cancer is likely to spread. Learn more about Radiation Therapy to Treat Cancer and Radiation Therapy Side Effects.

Sources: Radiation Therapy to Treat Cancer · Radiation Therapy Side Effects

Radiation therapy may be given after surgery for salivary gland cancer. Radiation therapy uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. Salivary gland cancer may be treated with external beam radiation therapy or internal radiation therapy if the cancer is likely to spread. Learn more about Radiation Therapy to Treat Cancer and Radiation Therapy Side Effects.

External beam radiation therapy uses a machine outside the body to send radiation toward the area of the body with cancer.

Internal radiation therapy, also called brachytherapy, uses a radioactive substance sealed in needles, seeds, wires, or catheters that are placed directly into or near the cancer.

Sources: radioactive · seeds · catheters

Targeted therapy (entrectinib or larotrectinib) may be used to treat recurrent childhood salivary gland cancer. Recurrent salivary gland cancer is cancer that has come back after it has been treated. Targeted therapy uses drugs or other substances to block the action of specific enzymes, proteins, or other molecules involved in the growth and spread of cancer cells. The doctor may suggest biomarker tests to help predict your child's response to certain targeted therapy drugs. Learn more about Biomarker Testing for Cancer Treatment and Targeted Therapy to Treat Cancer.

Sources: entrectinib · larotrectinib · Biomarker Testing for Cancer Treatment · Targeted Therapy to Treat Cancer

For patients

Side effects and late effects of treatment

Source: Childhood Salivary Gland Tumors (PDQ®)–Patient Version, National Cancer Institute.

Source updated: October 10, 2024. Captured 2026-09-09.

Cancer treatments can cause side effects. Which side effects your child might have depends on the type of treatment they receive, the dose, and how their body reacts. Talk with your child's treatment team about which side effects to look for and ways to manage them.

To learn more about side effects that begin during treatment for cancer, visit Side Effects.

Sources: side effects · Side Effects

Problems from cancer treatment that begin 6 months or later after treatment and continue for months or years are called late effects. Late effects of cancer treatment may include:

physical problems, such as:

physical problems, such as:

dry mouth

trouble seeing

numbness or weakness in the face

changes in the way the bones of the head and face grow

other changes in the child's appearance

changes in mood, feelings, thinking, learning, or memory

second cancers (new types of cancer)

Some late effects may be treated or controlled. It is important to talk with your child's doctors about the possible late effects caused by some treatments. Learn more about Late Effects of Treatment for Childhood Cancer.

Sources: Late Effects of Treatment for Childhood Cancer

Disease and treatment settings

Childhood Salivary Gland Tumors

Disease and treatment setting

Salivary Gland Tumors in children and adolescents